This collaboration between Eli Lilly and a Top VC fund can redefine how Corporate VC (CVC) fuels innovation – not just in ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The facility, backed by UVA, CvilleBioHub and a $4.3 million GO Virginia award, will bring lab breakthroughs to health care.

Young drugmakers confront several harsh realities this year, among them a contracting sector and competition from China.

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...

An official ribbon-cutting ceremony took place Friday for Amgen's new manufacturing plant in Holly Springs. It's at the CaMP ...

The biotechnology sector faces significant challenges in achieving efficiency within global financial markets. A recurring ...

Dear reader, biotech investments in the United States face unique challenges, chief among them the issue of "massive capital.

Investing in AI and Biotech Andreessen Horowitz, or a16z, is investing in AI and biotech to lead the way in innovation. It ...

Universal DX is focused on "cracking cancer’s code" via its multi-omics and machine learning models. Starting with colorectal ...